Daxor Co. (NYSE: DXR) has seen significant growth in the short-term interest rate in March. As of March 29, short-term interest totaled 234,045 shares, an increase of 1,257.4% from 17,242 shares on March 15. According to the average daily trading volume of 1,214,477 shares, the number of days and coverage is currently 0.2 days. At present, the company’s 33.3% stake is short selling.
In other news, Director Jonathan Adam Fair Xushu sold 19,194 shares of the company during the transaction on Thursday, March 15. The average price of the stock is $18.63 and the total value is $357,584.22. After the transaction was completed, the director now owns 3,908 shares of the company with a value of US$72,806.04. The transaction is disclosed in a legal filing with the Securities and Exchange Commission, and the transaction is accessible through this link. In addition, the Vice President of Sorens Thompson sold 2,950 shares of the company in a transaction that took place on Thursday, March 15. The average price of these stocks is $19.54 and the total value is $57,643.00. After the transaction was completed, the vice president now owns 950 shares of the company directly, worth approximately US$18,563. The disclosure of this sale can be found here. Insiders sold 79,944 shares of the company in the past 90 days worth US$994,627.
How to become a new stock millionaire
New York Stock Exchange: DXR fell $0.79 Tuesday to close at $8.51. The number of shares traded was 53,491 shares, and the average number was 557,301 shares. The one-year low of Dax was $3.40 and the one-year high was $21.66.
In addition, TheStreet raised Daxor’s stock from “d +” to “c-” on Tuesday, April 3rd.
Dassault company profile
Dassault is an investment company with medical instruments and biotechnology business. The company is short selling stocks. The company has a diversified portfolio of securities consisting mainly of ordinary and preferred shares of the power company